CurveBeam AI (ASX:CVB) Total Stockholders Equity: A$36.57 Mil (As of Dec. 2025)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

What is CurveBeam AI Total Stockholders Equity?

CurveBeam AI ASX:CVB Total Stockholders Equity is A$36.57 Mil as of Dec. 2025. The stock has 5 warning signs investors should review.

CurveBeam AI's Total Stockholders Equity for the quarter that ended in Dec. 2025 was A$36.57 Mil. It refers to the net assets owned by shareholders. It does not include minority interest.

Total Stockholders Equity is used to calculate Book Value per Share. CurveBeam AI's Book Value per Share for the quarter that ended in Dec. 2025 was A$0.08. The ratio of a company's debt over equity can be used to measure how leveraged this company is. CurveBeam AI's Debt-to-Equity for the quarter that ended in Dec. 2025 was 0.47.

CurveBeam AI  (ASX:CVB) Total Stockholders Equity Explanation

1. Total Stockholders Equity is used to calculate Book Value per Share.

CurveBeam AI's Book Value per Share for the quarter that ended in Dec. 2025 is

Book Value per Share=(Total Stockholders Equity-Preferred Stock)/Shares Outstanding (EOP)
=(36.568-0)/477.734
=0.08

2. The ratio of a company's debt over equity can be used to measure how leveraged this company is.

CurveBeam AI's Debt-to-Equity for the quarter that ended in Dec. 2025 is

Debt-to-Equity=Total Debt / Total Stockholders Equity
=(Short-Term Debt & Capital Lease Obligation + Long-Term Debt & Capital Lease Obligation) / Total Stockholders Equity
=(1.286 + 15.877) / 36.568
=0.47

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

CurveBeam AI Total Stockholders Equity Related Terms

CurveBeam AI Total Stockholders Equity Historical Data

* Premium members only.

The historical data trend for CurveBeam AI's Total Stockholders Equity can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

CurveBeam AI Total Stockholders Equity Chart

CurveBeam AI Annual Data
Trend Jun21 Jun22 Jun23 Jun24 Jun25
Total Stockholders Equity
0.00 0.00 -48.10 38.92 35.11

CurveBeam AI Semi-Annual Data
Jun21 Dec21 Jun22 Jun23 Dec23 Jun24 Dec24 Jun25 Dec25
Total Stockholders Equity Get a 7-Day Free Trial Premium Member Only 46.93 38.92 40.78 35.11 36.57
What does a Total Stockholders Equity of A$36.57 Mil mean?
CurveBeam AI (ASX:CVB) has a Total Stockholders Equity of A$36.57 Mil as of Dec. 2025. The total amount of shareholder's equity as recorded on a company's balance sheet. View historical data for CurveBeam AI and its competitors.
Is CurveBeam AI's Total Stockholders Equity too high?
CurveBeam AI's current Total Stockholders Equity is A$36.57 Mil.
How does CurveBeam AI's Total Stockholders Equity compare to ABT and SYK?
CurveBeam AI's Total Stockholders Equity of A$36.57 Mil can be compared against companies in the Medical Devices & Instruments industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Total Stockholders Equity for a Medical Devices & Instruments company?
A good Total Stockholders Equity depends on the Medical Devices & Instruments industry context. However, Total Stockholders Equity should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Total Stockholders Equity mean?
A high Total Stockholders Equity can signal that a stock is expensive relative to its fundamentals. The total amount of shareholder's equity as recorded on a company's balance sheet. View historical data for CurveBeam AI and its competitors. CurveBeam AI's current Total Stockholders Equity is A$36.57 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is CurveBeam AI stock overvalued right now?
CurveBeam AI (ASX:CVB) has a current Total Stockholders Equity of A$36.57 Mil. The current Total Stockholders Equity is A$36.57 Mil. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Total Stockholders Equity calculated?
Total Stockholders Equity is calculated from a company's financial statements. For CurveBeam AI (ASX:CVB), the current Total Stockholders Equity is A$36.57 Mil as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

CurveBeam AI Business Description

Address 10 Queen Street, Level 10, Melbourne, VIC, AUS, 3000
CurveBeam AI Ltd is a manufacturer of specialized imaging equipment that has developed software that, through the use of artificial intelligence (AI), and deep learning AI (DLAI), automates the scan processing and analysis of the high-quality images produced from the company's CT devices to assist in the clinical assessment. The company has one operating segment, being the research, design, manufacture and sale of cone beam CT imaging equipment for orthopaedic specialties, which includes the development, validation and preparation for commercialisation of a HRpQCT Medical Device and Software as a Service (SaaS) platform.